Fund Holdings — Omega Fund Management, LLC

Total Portfolio Value:
$169.46M
Total Bought:
$69.09M
Total Sold:
$57.8K
Net Transaction:
+$69.03M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kestra Med Technologies Ltd.
SHS
01,795,893+1,795,893$0$44.75M26.41%+$44.75M
Bicara Therapeutics Inc.2,204,6502,204,6500$38.41M$28.73M16.95%-$9.68M
Beta Bionics, Inc.(BBNX)01,988,287+1,988,287$0$24.34M14.36%+$24.34M
Nuvation Bio Inc.CL A(NUVB)13,072,34013,072,3400$34.77M$23.01M13.58%-$11.77M
Replimune Group, Inc.(REPL)1,975,2031,975,2030$23.92M$19.26M11.36%-$4.66M
Upstream Bio, Inc.(UPB)2,036,2932,036,2930$33.48M$12.46M7.35%-$21.01M
Lexeo Therapeutics, Inc.(LXEO)1,184,6361,184,6360$7.79M$4.11M2.43%-$3.68M
Alumis Inc.653,223653,2230$5.13M$4.01M2.37%-$1.12M
Ikena Oncology2,249,1232,249,1230$3.69M$2.88M1.70%-$809.7K
enGene Holdings Inc.
COM
526,357526,3570$3.50M$2.36M1.39%-$1.14M
Immunic, Inc.(IMUX)1,788,1601,788,1600$1.79M$1.95M1.15%+$160.9K
Sana Biotechnology, Inc.(SANA)843,750843,7500$1.38M$1.42M0.84%+$42.2K
enGene Holdings Inc.WARRANT
*W EXP 10/31/202
321,502321,5020$271.1K$192.9K0.11%-$78.2K
Syros Pharmaceuticals251,2700-251,270$57.8K$0—-$57.8K
Page 1 of 1
Omega Fund Management, LLC — 13F Holdings — Q1 2025 | TickerTrail